Dilip Shanghvi is the Founder and Managing Director of Sun Pharmaceutical Industries Limited (Sun Pharma). Sun Pharma is the fourth-largest specialty generic pharmaceutical company in the world, with global revenues of US$ 5.4 billion and a market cap of US$ 46.5 billion. Supported by 43 manufacturing facilities, Sun provides high-quality, affordable medicines trusted by healthcare professionals and patients in more than 100 countries across the globe. Dilip is also the Chairman of Sun Pharma Advanced Research Company Ltd., which is engaged in the R&D of innovative drugs and delivery technologies.

He was honoured with India's fourth highest Civilian National Award, the Padma Shri, in recognition of his distinguished contribution to the Indian Trade & Industry, in 2016. In 2018, the Indian Government appointed Dilip to India's Central Bank, RBI’s (Reserve Bank of India) 21-member central board committee. He is part of the Economic Advisory Council formed by the Government of Maharashtra, India to achieve rapid and comprehensive development in the state. The Government of Gujarat, India appointed him as the Chairman of Gujarat Biotechnology University in 2022.

Dilip has been conferred with many awards and recognitions. In 2023, 2021 & 2020, India’s leading magazine, India Today included him in its annual Power List of 50 influential personalities in India. Some of the other awards and recognitions bestowed on him include Moneycontrol Lifetime Achievement Award (2023), All India Management Association (AIMA) Entrepreneur of the Year (2017), NDTV Business Leader of the Year (2015), Forbes Entrepreneur for the year (2014), Economic Times’ Business Leader of the Year (2014), CNN IBN’s Indian of the Year – Business (2011), Business India’s Businessman of the Year (2011) and Ernst and Young’s World Entrepreneur of the Year (2011). He has also been awarded the Economic Times’ Entrepreneur of the Year (2008), Business Standard’s CEO of the Year (2008) and CNBC TV 18’s First Generation Entrepreneur of the Year (2007)

He is a former President of the Indian Pharmaceutical Alliance (IPA) and has also served as the chairman of the Board of Governors of the Indian Institute of Technology (Bombay). He is a former trustee of the Rhodes Scholarship Program at Oxford University.

In 2019, Dilip was conferred with an honorary doctorate by the Tel Aviv University, Israel’s largest and most comprehensive institution of higher learning.

Dilip has played a vital role in the globalisation of the Indian pharmaceutical industry and continues to inspire generations of entrepreneurs in their journey to success.